Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Debt Ratio (2016 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Debt Ratio for 5 consecutive years, with 0.23 as the latest value for Q4 2025.

  • On a quarterly basis, Debt Ratio fell 19.52% to 0.23 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.23, a 19.52% decrease, with the full-year FY2025 number at 0.23, down 19.52% from a year prior.
  • Debt Ratio was 0.23 for Q4 2025 at Rhythm Pharmaceuticals, up from 0.21 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.32 in Q4 2023 to a low of 0.21 in Q3 2025.
  • A 3-year average of 0.27 and a median of 0.28 in 2024 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: decreased 12.24% in 2024, then decreased 19.52% in 2025.
  • Rhythm Pharmaceuticals' Debt Ratio stood at 0.32 in 2023, then dropped by 12.24% to 0.28 in 2024, then dropped by 19.52% to 0.23 in 2025.
  • Per Business Quant, the three most recent readings for RYTM's Debt Ratio are 0.23 (Q4 2025), 0.21 (Q3 2025), and 0.29 (Q2 2025).